FDA approves Regeneron’s EYLEA HD for RVO and monthly dosing
November 25, 2025

FDA Approves EYLEA HD for RVO and Monthly Dosing Across Indications

A fresh FDA nod gives retina specialists more room to flex their dosing strategy.  It’s another busy day at the…

chiesi idebenone_thumbnail
September 23, 2025

FDA Grants Priority Review to Idebenone for Leber Hereditary Optic Neuropathy

A rare disease, a rare chance. FDA fast-tracks idebenone for LHON.  The U.S. Food and Drug Administration (FDA) doesn’t hand…

Discover our fascinating content at issuu

explore